While iHsp70 inhibition has been shown to reduce myocyte fibrosis, blocking Ec-Hsp70 with anti-Hsp70 antibodies has been shown to mitigate hypertension-induced cardiac hypertrophy and fibrosis [158]. This evidence concerns the gene HSPA1A and Hypertension.